- Futures on the DAX are trading higher today, and the cash DAX is up nearly 0.5 percent. Almost all sectors in the index are posting gains.
- Strong earnings from Lululemon Athletica (LULU.US) supported sentiment toward German footwear and apparel companies Adidas (ADS.DE) and Puma (PUM.DE).
- AQR Capital has disclosed a short position in BASF (BAS.DE), yet shares of the chemical giant are trading higher today regardless.
- EasyJet (EZJ.UK) was downgraded to “hold” from “buy”; the price target was cut to 520 pence (from 650 pence). Shares of the company are rising despite the downgrade.
DE40 Index (D1 timeframe)
DAX futures are maintaining upward momentum on the last trading session of the week. The main challenge for the bulls today is to push above 24,500 points, which could potentially open the path to new record highs.
Source: xStation5
Source: Bloomberg Finance LP
Lufthansa shares gain after Kepler Cheuvreux report
Lufthansa shares are up as much as 6.9 percent, reaching their highest intraday level since August 2023. Kepler Cheuvreux upgraded the German flagship carrier to “buy” from “hold,” pointing to an increasingly attractive risk-to-reward profile and supportive factors heading into next year. The price target was raised to 11 euros (from 7.50 euros).
- The upside potential, analysts note, is “hard to ignore,” highlighting the successful restructuring, a possible recovery in the U.S. economy, and the potential reopening of Russian airspace.
- Additionally, industry-wide capacity constraints and low fuel prices create a supportive market backdrop.
- At the same time, challenges remain, including pressure from labor unions, competition from Middle Eastern carriers, the group’s complex structure, and operational risks.
Source: xStation5
Daily Summary: End of the week in the red, tech rally waning
Three Markets to Watch Next Week (12.12.2025)
Rivian Automotive: Rising star or a meteorite?
Technology companies declines 📉🖥️
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
